1. M. Chalia, C.W. Lee, L.A. Dempsey, A.D. Edwards, H. Singh, A.D. Michell, N.L. Everdell, J.C. Hebden, R.J. Cooper, T. Austin. The haemodynamic response to burst-suppressed and discontinuous EEG activity in infants with hypoxic-ishcaemic encephalopathy. Neurophoton. 3(3), 031408 (2016), doi: 10.1117/1.NPh.3.3.031408.
  2. H. Singh, R.J. Cooper, C.W. Lee, L.A. Dempsey, S. Brigadoi, A. Edwards, D. Airantzis, N. Everdell, A. Michell, D. Holder, T. Austin, J.C. Hebden. Neurovascular interactions in the neurologically compromised neonatal brain. Adv. Exp. Med. Biol. 2016; 876: 485-92.
  3. L.A. Dempsey, R.J. Cooper, S. Powell, A. Edwards, C.W. Lee, S. Brigadoi, N. Everdell, S. Arridge, A.P. Gibson, T. Austin, J.C. Hebden. Whole-head functional brain imaging of neonates at cot-side using time-resolved diffuse optical tomography. Proc. SPIE 9538, Diffuse Optical Imaging V, 953818 (July 16, 2015); doi:10.1117/12.2190420
  4. A.M. Plomgaard, C. Hagmann, T. Alderliesten, T. Austin, F. van Bel, O. Claris, E. Dempsey, A. Franz, M. Fumagalli, C. Gluud, G. Greisen, S. Hyttel-Sørensen, P. Lemmers, A. Pellicer, G. Pichler, M. Benders. Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments. Pediatr Res. 2015 doi: 10.1038/pr.2015.239.
  5. J. Riera, S. Hyttel-Sorensen, M.C. Bravo, F. Cabañas, P. López-Ortego, L. Sanchez, M. Ybarra, E. Dempsey, G. Greisen, T. Austin, O. Claris, M. Fumagalli, C. Gluud, P. Lemmers, G. Pichler, A.M. Plomgaard, F. van Bel, M. Wolf, A. Pellicer. The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings. Arch Dis Child. 2015 doi: 10.1136/archdischild-2015-308829.
  6. A.M. Plomgaard, W. van Oeveren, T.H. Petersen, T. Alderliesten, T. Austin, F. van Bel, M. Benders, O. Claris, E. Dempsey, A. Franz, M. Fumagalli, C. Gluud, C. Hagmann, S. Hyttel-Sorensen, P. Lemmers, A. Pellicer, G. Pichler, P. Winkel, G. Greisen. The SafeBoosC II randomised trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury. Pediatr Res. 2015 doi: 10.1038/pr.2015.266.
  7. C.S.Costa, M. Czosnyka, S. Mitra, P. Smielewski, T. Austin. Monitoring of cerebrovascular reactivity allows determination of optimal blood pressure in preterm infants. J Pediatr. 2015 Jul;167(1):86-91. doi: 10.1016/j.jpeds.2015.03.041.
  8. S. Hyttel-Sørensen, A.Pellicer, T. Aldrliesten, T.Austin, F.van Bel, M Benders, O Claris, E.M.Dempsey, A.R.Franz,  M.Fumagalli, C. Gluud,  B. Grevstad, C.Hagmann, P.Lemmers, G.Naulaers, W.van Oeveren,  G.Pichler, A.M.Plomgaard, J.Riera, L.Sanchez, P Winkel, M.Wolf, G.Greisen. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ 2015;350:g7635 doi: 10.1136/bmj.g7635
  9. L.A. Dempsey, R.J. Cooper, T. Roque, T. Correia, E. Magee, S. Powell, A.P. Gibson, J.C. Hebden. A data-driven approach to optimum wavelength selection for diffuse optical imaging. J Biomed Opt. 2015 Jan 1;20(1):16003.
  10. H. Singh, R.J.Cooper, C.W.Lee, L.Dempsey, A.Edwards, S.Brigadoi, D.Airantzis, N.Everdell, A.Michell, D.Holder, J.C.Hebden, T.Austin. Mapping cortical haemodynamics during neonatal seizures using diffuse optical tomography: a case study. Neuroimage Clin. 2014;5:256-65.
  11. S.Brigadoi, P. Aljabar, M. Kuklisova-Murgasova, S.R.Arridge, R.J. Cooper. A 4D neonatal head model for diffuse optical imaging of preterm to term infants. Neuroimage. 2014 Oct 15;100:385-94.
  12. T.Dassios, T.Austin. Respiratory function parameters in ventilated newborn infants undergoing whole body hypothermia. Acta Paediatrica. 2014;103:157-161.
  13. S.Mitra, M.Czosnyka, P.Smielewski, H.O’Reilly, K.Brady, T.Austin. Heart rate passivity of cerebral tissue oxygenation as an indicator of cerebrovascular reactivity in preterm infants. Acta Paediatr. 2014;103(9):e374-82
  14. R.J. Cooper, E. Magee, N. Everdell, S. Magazov, M. Vaerla, D. Airantzis, A.P. Gibson, J.C. Hebden. MONSTIR II: A 32-channel, multispectral, time-resolved optical tomography system for neonatal brain imaging. Rev Sci Instrum. 2014 May;85(5):053105. doi: 10.1063/1.4875593.
  15. S. Hyttel-Sørensen, T.Austin, F.van Bel, M Benders, O Claris, E.M.Dempsey, M.Fumagalli, C.Gluud, C.Hagmann, L.Hellström-Westas, P.Lemmers, G.Naulaers, W.van Oeveren, A.Pellicer, G.Pichler, C.Roll, L.S.Støy, M.Wolf, G.Greisen. Clinical use of cerebral oximetry in extremely preterm infants is feasible. Dan Med J. 2013;60:A4533.
  16. S. Hyttel-Sørensen, T.Austin, F.van Bel, M Benders, O Claris, E.M.Dempsey, M.Fumagalli, G.Greisen, B. Grevstad, C.Hagmann, L.Hellström-Westas, P.Lemmers, G.Naulaers, W.van Oeveren, A.Pellicer, G.Pichler, C.Roll, M Skoog, P Winkel, M.Wolf, C.Gluud. A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial. Trials 2013;14:120.
  17. A.Pellicer, M Benders, O Claris, E.M.Dempsey, M.Fumagalli, C.Gluud, G.Greisen, C.Hagmann, L.Hellström-Westas, S.Hyttel-Sørensen, P.Lemmers, G.Naulaers, G.Pichler, C.Roll, F.van Bel, W.van Oeveren, M Skoog, M.Wolf, T.Austin. The SafeBoosC phase II randomized clinical trial: a treatment guideline for targeted near-infrared derived cerebral tissue oxygenation in extremely preterm infants. Neonatology 2013;104:171–178.
  18. R.Chaudhary, K.Farrer, S. Broster, L.McRitchie, T.Austin. Active versus passive cooling during neonatal transport. Pediatrics 2013;132:841-6.
  19. R.J.Cooper, J.C.Hebden, H.O’Reilly, S.Mitra, A.Michell, N.L.Everdell, A.P.Gibson, T. Austin. Transient haemodynamic events in neurologically compromised infants: A simultaneous EEG and diffuse optical imaging study. Neuroimage 2011;55:1610-6.